Skip to main content
. 2019 May 14;39(5):BSR20190116. doi: 10.1042/BSR20190116

Table 3. Univariate and multivariate analysis (Cox regression model) of OS and DFS in relation to various parameters and TSLP overexpression.

Parameter OS DFS
Univariate# Multivariate## Univariate# Multivariate##
P value P value Risk ratio (95% CI) P value P value Risk ratio (95% CI)
TSLP IHC <0.001* <0.001* 7.308 <0.001* <0.001* 7.399
  Low(-)/Over(+) (3.538–15.09) (3.507–15.61)
Age, y 0.001* 0.150 1.428 0.001* 0.115 1.486
  <60/≥60 (0.879–2.321) (0.908–2.432)
FIGO stage <0.001* 0.834 1.069 0.000* 0.725 1.117
  <IIIC//≥IIIC (0.573–1.992) (0.602–2.074)
Histologic differentiation 0.006* 0.495 1.331 0.005* 0.917 0.962
  Well/Mod and poorly (0.585–3.027) (0.465–1.990)
Pelvic involvement <0.001* <0.001* 3.718 0.000* 0.003* 2.731
  No/Yes (1.837–7.526) (1.396–5.343)
Lymph node involvement 0.010* 0.210 1.416 0.009* 0.202 1.428
  No/Yes (0.822–2.438) (0.826–2.468)
Presence of ascites 0.078 0.086
  No/Yes
Menopause 0.106 0.093
  No/Yes

TSLP IHC Low expression: total score 0–4; TSLP IHC Overexpression: total score 5–12.

OS: the time between the date of initial diagnosis and death or last contact;

DFS: the time between the date of surgery and identification of disease recurrence;

CI: confidence interval.

#

Statistical analyses were performed by log-rank test.

##

Statistical analyses were performed by Cox regression model.

*

P<0.05 was considered significant.